Jubilant Pharmova P/E Ratio
JUBLPHARMA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
30.28
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
30.28
Current Price
₹869.40
EPS (TTM)
₹52.99
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
19.63
Historical Range
9.61 - 39.54
Percentile
83.3%
Sector Context
Sector Average
47.62
Sector Median
25.5
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹27.31
Sept 2025
₹7.59
Mar 2025
₹9.71
Key P/E Ratio Insights for Jubilant Pharmova
- Stock appears overvalued with PE of 30.28, suggesting caution for new investments
- Current PE is 54.3% above historical average
- Trading at discount to sector average PE of 47.62
P/E Ratio Historical Trend for Jubilant Pharmova
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Jubilant Pharmova
Additional stock information and data for JUBLPHARMA
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 39.54 | 27.31 | ₹1079.90 | NSE | High |
| 2021 | 23.87 | 35.69 | ₹851.80 | NSE | Moderate |
| 2020 | 9.61 | 55.4 | ₹532.65 | NSE | Low |
| 2018 | 14.62 | 53.18 | ₹777.60 | NSE | Low |
| 2017 | 15.19 | 40.94 | ₹621.95 | NSE | Moderate |
| 2016 | 14.93 | 28.06 | ₹419.05 | NSE | Low |
Sector P/E Ratio Comparison
Comparing Jubilant Pharmova with other companies in Healthcare sector
Sector Average
47.62
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.83 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.53 | ₹1,133 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Brooks Laboratories | BROOKS | 6.14 | ₹157 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.15 | ₹2,100 | Low |
| Galaxy Medicare | GML | 7.41 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.35 | ₹34 | Low |